Silver Spring, MD – Pet owners now have a more affordable option for treating skin infections in cats and dogs, thanks to a new generic drug approval announced Tuesday.
The U.S. Food and Drug Administration approved the first generic version of cefovecin sodium injection, used for the treatment of common skin infections in pets, including abscesses and wounds caused by certain bacterial strains.
According to the FDA, the new generic drug contains the same active ingredient as the brand name product Convenia, originally approved in 2008. The agency also confirmed the generic formulation has no inactive ingredients that would affect the drug’s effectiveness.
The antimicrobial injection is available only by prescription and must be administered by a licensed veterinarian. It is supplied in a multi-use vial with an 80 mg/mL concentration when mixed with 10 mL of sterile water.
The generic cefovecin sodium injection is manufactured by Qilu Animal Health Products Co., Ltd., a pharmaceutical company based in Shandong, China. FDA officials say the approval is part of an ongoing effort to expand access to effective veterinary treatments while offering more affordable options for pet care.
Veterinarians frequently use cefovecin to treat skin conditions in animals, particularly in cases where oral antibiotics may be difficult to administer.
With this generic option now available, veterinarians and pet owners may benefit from increased accessibility and cost savings while maintaining effective treatment standards.
This article was produced by a journalist and may include AI-assisted input. All content is reviewed for accuracy and fairness.
Follow us on Instagram & Facebook for more relevant new stories and SUPPORT LOCAL INDEPENDENT NEWS! Have a tip? Message us!
